Advisory Board September 27, 2023
As more people take new weight-loss drugs, such as semaglutide, there are a growing number of reports of potential side effects, including severe mental health issues — leading drug regulators in Europe to investigate the safety of these drugs.
Are new weight-loss drugs leading to mental health issues?
Semaglutide mimics a hormone called glucagon-like peptide-1 (GLP-1) to targets areas of the brain that regulate appetite and food intake. The drug is available in two forms: Ozempic, a diabetes treatment, and Wegovy, a higher dose of the drug for weight loss.
As more people take semaglutide, there...